What is C16 Biosciences?
Operating under the brand name Palmless, C16 Biosciences specializes in the development of sustainable, biomanufactured ingredients designed for the beauty, food, and personal care industries. By leveraging innovative fermentation technology, the company provides high-performance, precise alternatives that address critical supply chain vulnerabilities. Their market position is defined by a commitment to redefining natural ingredients, offering formulators and brand leaders a scalable, eco-friendly solution that mitigates the ecological footprint associated with conventional palm oil sourcing.
How much funding has C16 Biosciences raised?
C16 Biosciences has raised a total of $24.5M across 3 funding rounds:
Series A
$20M
Other Financing Round
$1M
Grant
$3.5M
Series A (2020): $20M with participation from Y Combinator, DCVC, Breakthrough Energy Ventures, Liquid 2 Ventures, AME Cloud Ventures, Future Tech Labs, Sound Ventures, and Waldencast
Other Financing Round (2024): $1M led by Elemental Excelerator
Grant (2024): $3.5M supported by Bill & Melinda Gates Foundation
Key Investors in C16 Biosciences
DCVC
A deep tech venture capital firm that leverages artificial intelligence to unlock potential in biotechnology and sustainable agriculture, supporting founders tackling global challenges.
Breakthrough Energy Ventures
An investment firm backed by global business leaders that provides risk-tolerant capital to companies capable of significantly reducing emissions across agriculture and manufacturing.
Bill & Melinda Gates Foundation
A global philanthropic organization that supports innovative solutions to improve health outcomes and address extreme poverty, often backing transformative technologies with significant social impact.
What's next for C16 Biosciences?
With this latest capital injection, C16 Biosciences is poised to accelerate its enterprise-level growth strategy. The company is expected to focus on scaling its fermentation infrastructure to meet rising demand from global consumer packaged goods leaders. By bridging the gap between laboratory-scale innovation and industrial-grade production, C16 Biosciences aims to solidify its role as a foundational player in the green chemistry revolution, effectively replacing high-impact agricultural commodities with sustainable, data-driven alternatives.
See full C16 Biosciences company page
